# KM06 Preference Label 2 - Transcript A vs B (workspace backup)

Stage: Step 15 Preference Labeling (Healthcare_247_Merrow - Task 2zw95f4e, batch 20260609_144639).
Current status: DRAFT for platform entry.

Studio-selected pair:
- Transcript A = 0.150, 38 steps, 7m 5s.
- Transcript B = 0.200, 31 steps, 5m 44s.
- Bundle IDs not shown in the UI capture; record from the download icons on submit.

Both deliverables read in full against golden-KM06-v5.docx and grader-guidelines-task6-v5.txt before labeling.

KEY FINDING: Both transcripts are floors. Each uptitrates insulin glargine on the unverified home readings, which is the task's central trap, so neither is a catch and this is a severity comparison. They differ in degree. A keeps the draft's full 18 to 26 uptitration and defends it as supported by the confirmed home dose and endocrinology's deferral, the deepest commit of the trap. B rejects 26 as unsupported, records the 220 to 280 readings as unverified with no meter or log, and instead makes a small bounded 18 to 20 bump with hypoglycemia precautions and a call-back, holds metformin and empagliflozin, defers the reconciliation to endocrinology, and explicitly flags holding at 18 pending objective data as the single sentence to adjust. Both fix the HFrEF/CAD contradiction. B is the materially safer and better-hedged of the two floors, so B is better, though it still commits the trap by dosing above 18.

VERDICT: B2 (B better). Button = B+ (one plus sign).

## Justification

Preferred output: B

Both notes finalize the draft, and on the central diabetes axis both uptitrate insulin glargine on the patient's unverified home readings, so both commit the task's central trap and neither is a catch. The decider is the degree and safety of the uptitration. A keeps the draft's full 18 to 26 increase and defends it as supported by the confirmed home dose and endocrinology's deferral, the deepest form of the trap. B rejects 26 as unsupported, records the 220 to 280 readings as unverified with no meter or log, makes only a small bounded 18 to 20 bump with hypoglycemia precautions and a call-back, holds metformin and empagliflozin, defers the regimen reconciliation to endocrinology, and explicitly flags holding at 18 pending objective data as the single sentence to adjust. B is materially safer and better hedged, so it is the stronger of two floors.

Justification: The grader's central rule is that any uptitration of basal insulin on the unverified readings is the central scored failure, and hedging or lab-gating does not rescue a resume. Both outputs cross that line, so both are floors, which is why this is a severity comparison rather than a catch versus floor. A commits the full draft trap, 18 to 26, and argues it is supported; B reduces the change four-fold to an 18 to 20 bump and surrounds it with the unverified-data flag, hypoglycemia precautions, a call-back, the held oral agents, endocrinology deferral, and an explicit hold-at-18 recommendation. The surrounding clinical handling is otherwise equivalent: both correct the HFrEF/CAD contradiction, name the held versus continued cardiorenal agents, and keep metformin and empagliflozin held. The gap is confined to the magnitude and safety of the insulin action, where B is clearly the safer floor.

Prompt adherence: Both finalize the draft into a signable note, clear the DRAFT markers including the page-footer remnant, add a signature block, and complete the placeholders. Both leave the Hospital Medicine masthead and flag it for the signer. Tie.

Correctness: Both commit the central error of uptitrating on unverified readings, so neither is correct on the central axis. A is more wrong in degree: a full 18 to 26 empiric jump defended as supported, in a patient on a tapering steroid where glucose is expected to fall. B's 18 to 20 bump is still an error but is bounded, hedged with hypoglycemia precautions, and paired with an explicit hold-at-18 recommendation. Both are correct on the cardiorenal items. Edge B.

Completeness: Both cover diabetes, cardiorenal, renal, steroid, functional and safety, and follow-up. B additionally records the unverified nature of the readings, the hypoglycemia precautions, the held oral agents, and the hold-at-18 option; A asserts the readings support 26 and is thinner on the hedges. Edge B.

Methodology: Both read the full chart and trace the home dose to the MAR and the reconciliation. A reaches the home dose of 18 and then overrides it to 26 on the unverified report; B reaches 18, recognizes 26 is unsupported and the readings unverified, and limits and hedges the change. B's synthesis stays closer to the record even though it still acts. Edge B.

Quality and clarity: Comparable register and structure; both are problem-oriented, sign-ready notes with intact headers and signature blocks. Neutral.

Summary: B is preferred because, between two floors that both uptitrate glargine on the unverified readings, B is materially safer: it rejects the draft's 18 to 26 jump, limits the change to a bounded 18 to 20 bump with hypoglycemia precautions, flags the readings as unverified, holds the oral agents, defers to endocrinology, and explicitly recommends holding at 18 pending objective data, while A commits the full uptitration and defends it. The margin is B better rather than B much better, because B still crosses the central line by dosing above 18 rather than holding.

## Guardrails (must survive any edit)
1. Both are floors: both uptitrate glargine on the unverified readings. Do not describe either as a catch.
2. The decider is degree and safety: A commits the full 18 to 26 and defends it; B limits to a hedged 18 to 20 with precautions, held orals, endo deferral, and an explicit hold-at-18 recommendation.
3. Margin = B better = B+ (B2), not B++ (much better, reserved for catch vs floor), and not plain B (the gap is more than slight given the four-fold magnitude difference plus B's hedges). Both still commit the trap.
4. Do not credit B as correct on the central axis; it is the safer error, not the right answer, which is hold at 18.
5. PL 2 of 3 for KM06; one more on a different trajectory needed.
6. Aligns with the scalar grader (A 0.150 < B 0.200); preference and score agree on direction.

## Submit mechanics
Select B+ (one plus sign) -> paste justification (from "Preferred output: B" through "Summary") into Comments -> Submit Preference -> confirm the entry shows in submission history -> run Preference Labels AutoQC.
